1. Introduction to Becton, Dickinson and Company

Becton, Dickinson and Company (BD) is a global medical technology powerhouse headquartered in Franklin Lakes, New Jersey, USA. With a rich history spanning over 125 years, BD is a Fortune 500 company that generates approximately $19 billion in annual revenue and employs more than 70,000 professionals worldwide. The company is a leader in the healthcare industry, specializing in medical devices, diagnostic systems, and biosciences. BD's products are critical for hospitals, clinical laboratories, pharmaceutical companies, and research institutions across the globe. The company's reputation for quality, innovation, and reliability has made it a trusted partner in advancing health equity and improving patient outcomes. BD's extensive portfolio includes syringes, infusion pumps, blood collection systems, and advanced diagnostic platforms, serving both acute care and chronic disease management. The company's commitment to its mission 'Helping all people live healthy lives' drives its strategic initiatives, including a strong focus on sustainability, digital transformation, and personalized medicine. As a top Healthcare company, BD consistently ranks among the World's Most Admired Companies by Fortune and is recognized for its ethical practices and corporate responsibility. Organizations that rely on BD services include large hospital systems, government health agencies, and leading research universities, all of whom benefit from BD's end-to-end solutions that improve efficiency, reduce costs, and enhance patient care. The company's deep expertise in medication management, infection prevention, and diagnostic testing positions it as an indispensable ally in the fight against healthcare-associated infections and the opioid crisis. BD's global footprint includes manufacturing facilities in over 50 countries and a robust distribution network that ensures products reach healthcare providers in even the most remote areas. The company's innovative culture is fueled by significant investment in R&D, with over $1.5 billion allocated annually to develop next-generation technologies such as smart connected devices and AI-driven diagnostics. BD's leadership in the industry is further validated by its extensive patent portfolio and numerous regulatory approvals from the FDA, CE marking, and other global bodies. The company's commitment to diversity, equity, and inclusion (DEI) is evident in its workforce and supplier diversity programs, making it a preferred employer for top talent. In summary, Becton, Dickinson and Company is not just a manufacturer; it is a transformative force that shapes the future of healthcare through relentless innovation, operational excellence, and a steadfast dedication to the well-being of patients and clinicians worldwide.

2. Company History and Business Evolution

Becton, Dickinson and Company was founded in 1897 by Maxwell W. Becton and Fairleigh S. Dickinson, two young entrepreneurs with a vision to improve medical practice through innovative products. The company's first success was the production of the world's first heat-sterilizable syringe, a breakthrough that dramatically reduced infection rates in hospitals. Over the next few decades, BD expanded its product line to include hypodermic needles, blood collection tubes, and clinical thermometers, becoming a staple in the emerging field of modern medicine. In the 1920s, BD introduced the first disposable blood lancet, setting the stage for the company's leadership in single-use devices. World War II marked a turning point, as BD supplied large quantities of syringes and needles to the military, establishing its reputation for mass production and reliability. The post-war era saw BD go public in 1961 and list on the New York Stock Exchange (NYSE: BDX). The 1970s and 1980s were characterized by aggressive expansion through acquisitions, including the purchase of Diagnostic Products Corporation in 1971 and the Becton Dickinson Vacutainer Systems division. These moves solidified BD's dominance in blood collection and diagnostic testing. The 1990s brought a focus on biosciences with the launch of the FACSCalibur flow cytometer, a pioneering tool for cell analysis. In 1999, BD acquired Pharmassist, a leader in automated medication dispensing, entering the pharmacy automation market. The 21st century witnessed a series of transformative acquisitions: C. R. Bard in 2017 for $24 billion, making BD a leader in urology and vascular access; CareFusion in 2015 for $12.2 billion, strengthening its medication management portfolio; and the acquisition of KCI Medical in 2021 to expand into wound care and negative pressure wound therapy. Under the leadership of CEO Tom Polen (appointed in 2019), BD has undergone a digital transformation, launching BD HealthSuite, a cloud-based platform for connected care. The company also divested non-core businesses like its surgical blades division to sharpen focus. Today, BD operates through three segments: BD Medical (medication delivery and management), BD Life Sciences (diagnostics and biosciences), and BD Interventional (peripheral intervention and urology). The company's evolution from a small syringe manufacturer to a global med-tech titan reflects its ability to anticipate healthcare trends and adapt through innovation and strategic M&A. BD's history is also marked by resilience during crises, such as its rapid ramp-up of syringe production during the COVID-19 pandemic to support vaccine distribution. The company's archives at the Franklin Lakes headquarters house over a century of medical artifacts, underscoring its enduring legacy. As BD moves forward, it continues to honor its founders' legacy by pushing boundaries in precision medicine, robotics, and sustainable healthcare solutions.

3. Becton, Dickinson and Company at a Glance

• Company Name: Becton, Dickinson and Company (BD)
• Headquarters: Franklin Lakes, New Jersey, United States
• Founded: 1897 by Maxwell W. Becton and Fairleigh S. Dickinson
• CEO: Tom Polen (since 2019)
• Revenue: $19.3 billion (fiscal year 2023)
• Employees: Approximately 70,000 globally
• Stock Symbol: NYSE: BDX
• Industry: Medical Devices, Diagnostics, Biosciences
• Fortune 500 Rank: #231 (2023)
• Global Presence: Operations in 50+ countries
• Segments: BD Medical, BD Life Sciences, BD Interventional
• Key Products: Syringes, needles, blood collection tubes, infusion pumps, flow cytometers, diagnostic assays, surgical instruments
• Major Acquisitions: C. R. Bard (2017), CareFusion (2015), KCI Medical (2021)
• R&D Spend: Over $1.5 billion annually
• Certifications: ISO 13485, FDA QSR, CE Mark, MDSAP
• Awards: Fortune World's Most Admired Companies, Forbes Best Employers for Diversity
• Sustainability Goal: Carbon neutral by 2040
• Key Customers: Hospitals, clinics, labs, pharmaceutical companies, research institutes
• Digital Platform: BD HealthSuite
• Philanthropy: BD Foundation supports global health equity and STEM education

4. Mission, Vision, and Core Corporate Values

Becton, Dickinson and Company's mission statement is 'Helping all people live healthy lives.' This simple yet profound vision drives every aspect of the organization, from product design to community engagement. BD envisions a future where healthcare is more accessible, affordable, and connected, with its technologies enabling early diagnosis, precision treatment, and seamless care coordination. The company's core values are embedded in its culture: Integrity, Customer Focus, Innovation, Collaboration, and Accountability. Integrity means doing the right thing always, maintaining transparency in reporting, and upholding the highest ethical standards in all interactions. Customer focus goes beyond meeting requirements; BD strives to anticipate the needs of clinicians, patients, and healthcare systems to deliver solutions that truly matter. Innovation is the lifeblood of BD, nurtured through a dedicated innovation center, partnerships with startups, and a culture that encourages calculated risk-taking. Collaboration emphasizes teamwork across functions and geographies, recognizing that the best solutions come from diverse perspectives. Accountability ensures that every employee takes ownership of their decisions and outcomes, contributing to a culture of continuous improvement. These values are reinforced through employee training, performance metrics, and recognition programs. BD also publishes an annual Corporate Social Responsibility (CSR) report that details progress on sustainability, DEI, and ethical supply chain practices. The company's values are not just words on a website; they are lived daily through initiatives like the BD Health Equity Framework, which aims to reduce disparities in healthcare access. For example, BD partners with organizations like Project HOPE to provide training on safe injection practices in underserved regions. The company's commitment to integrity is particularly notable given its role in disposing of medical waste safely and reducing environmental impact. BD's vision for the future includes fully integrated digital ecosystems that connect devices across the care continuum, enabling real-time data analytics and personalized medicine. By aligning its mission, vision, and values, BD creates a strong brand identity that attracts like-minded employees and partners who share a passion for improving global health.

5. Business Strategy and Future Roadmap

Becton, Dickinson and Company's business strategy is built on three pillars: accelerating innovation, expanding its portfolio through strategic M&A, and driving operational excellence. To accelerate innovation, BD invests heavily in digital health, connected devices, and artificial intelligence. The BD HealthSuite platform is central to this strategy, enabling healthcare providers to collect, analyze, and act on data from BD devices in real time. BD also focuses on breakthrough technologies such as the BD Rhapsody single-cell multiomics platform, which advances genomics research, and the BD Pyxis automated medication dispensing system, which enhances pharmacy workflow. In terms of M&A, BD has a disciplined approach, targeting companies with high-growth potential in areas like peripheral intervention, urology, and wound care. The acquisition of KCI Medical brought advanced negative pressure wound therapy, while the Bard acquisition added a $10 billion revenue stream. Operational excellence is achieved through lean manufacturing, automation, and supply chain digitization. BD’s 'Vision 2025' plan includes reducing manufacturing costs by 5% annually through process improvements. The future roadmap focuses on three megatrends: the shift from hospital to home care, the rise of chronic disease management, and the need for pandemic preparedness. BD is developing portable diagnostic devices for point-of-care testing and wearable drug delivery systems. The company also plans to expand in emerging markets like China and India, where regulatory changes are opening doors for advanced medical devices. Sustainability is a core component of the roadmap, with goals to achieve carbon neutrality by 2040 and zero waste to landfill by 2030. BD is already powering many facilities with renewable energy and reducing plastic use in packaging. The company's strategy also includes building a resilient supply chain by nearshoring critical components and diversifying suppliers. To measure progress, BD uses clear KPIs such as new product revenue (targeting 30% of total revenue from products launched in the last three years) and customer satisfaction scores. BD’s leadership regularly communicates this strategy through investor days, earning it strong support from shareholders. With a solid balance sheet and strong free cash flow, BD is well-positioned to navigate market volatility and continue its growth trajectory. The future roadmap is dynamic, with a focus on agility to adapt to emerging health crises, such as the recent monkeypox outbreak where BD quickly provided diagnostic kits. Ultimately, BD's strategy ensures it remains at the forefront of medical innovation while delivering substantial value to patients, providers, and investors.

6. Products, Technologies, and Services

Becton, Dickinson and Company offers an extensive range of products and services that span the entire healthcare continuum. The BD Medical segment includes medication delivery devices (syringes, needles, pen needles, infusion pumps), medication management solutions (BD Pyxis systems, dose verification software), and pharmaceutical systems (pre-fillable syringes, glass vials). These products are designed to improve safety, reduce errors, and enhance patient compliance. For example, the BD Alaris infusion pump integrates with electronic health records (EHRs) to automatically adjust drug dosing. The BD Life Sciences segment provides diagnostic systems (BD Vacutainer blood collection tubes, BD Bactec microbial detection systems, BD FACSCanto flow cytometers), as well as reagents and assays for infectious diseases, oncology, and immunology. The BD Interventional segment includes vascular access devices (BD Nexiva IV catheters, Bard Ports), surgical instruments (trocars, retrieval bags), and wound care products (KCI V.A.C. therapy devices). BD also offers software and services such as BD HealthSuite, BD Synapsys for pharma workflows, and training programs for healthcare professionals. Key technologies include the BD Kiestra microbiology automation system, which increases lab efficiency, and the BD Veritor Plus rapid diagnostic platform for group A strep, flu, and RSV. In the biosciences arena, BD is a leader in flow cytometry with products like the BD FACSCelesta and BD FACSymphony for cell analysis. BD also provides professional services like consulting on medication safety and infection prevention. The company's service offerings extend to managed equipment services, calibration, and preventive maintenance programs. BD's product development is guided by user-centered design, involving clinicians early in the process. The company holds numerous patents, including smart needle technology that prevents needlestick injuries. BD's commitment to quality is reflected in its rigorous testing and regulatory compliance. The company also offers environmentally friendly alternatives, like the BD EcoLine line of recyclable syringes. Product availability is supported by a vast distribution network that includes direct sales, distributors, and an e-commerce platform. BD's services, such as the BD Clinical Excellence Program, provide educational resources to help healthcare organizations achieve better outcomes. Through continuous innovation, BD ensures that its products address evolving market needs, such as the growing demand for home healthcare devices during the pandemic. The breadth and depth of BD's portfolio make it a one-stop-shop for many healthcare providers, reducing the need for multiple vendors. This comprehensive approach is a key competitive advantage.

7. Industries and Markets Served

Becton, Dickinson and Company serves a diverse array of industries and markets, each with unique needs. The primary market is acute care hospitals, where BD products are used in emergency departments, operating rooms, ICUs, and nursing units. Other healthcare providers include integrated delivery networks (IDNs), community hospitals, outpatient clinics, and long-term care facilities. Clinical laboratories, both hospital-based and independent, are major consumers of BD's diagnostic products, such as blood collection tubes and microbiology systems. The pharmaceutical industry relies on BD for drug delivery systems, including pre-fillable syringes and auto-injectors, as well as for contract manufacturing services. Research institutions, including academic medical centers and biotechnology companies, use BD's flow cytometers and cell analysis tools for genomics and drug discovery. Additionally, BD serves the veterinary market with animal health products, diagnostics, and surgical instruments. Emerging markets in Asia, Latin America, and the Middle East are growing rapidly due to rising healthcare spending and infrastructure improvements. BD also participates in the home healthcare market with products like insulin pens and infusion sets for diabetic patients. The company's interventional products are used in interventional radiology, cardiology, and urology departments. BD provides solutions for infection prevention, including room disinfection systems (like the BD Prism UV-C device) for hospitals. The company also serves government agencies, including the U.S. Department of Defense and the Centers for Disease Control and Prevention (CDC), providing critical medical supplies during public health emergencies. The biosciences segment serves the life sciences industry, including pharmaceutical R&D and academic labs. BD's market segmentation allows tailored strategies: for example, offering value-based bundles to IDNs focused on reducing costs per episode. The company's global reach means it adapts products to meet local regulatory requirements and cultural preferences. BD's market leadership is particularly strong in blood collection (80% market share in the U.S.) and in flow cytometry (over 40% market share). By serving such a wide range of industries, BD diversifies its revenue streams and reduces dependency on any single market, ensuring stability and growth. The company's deep understanding of clinical workflows enables it to innovate solutions that seamlessly integrate into existing processes, making it a trusted partner for hospitals and labs worldwide.

8. Leadership and Management Philosophy

Becton, Dickinson and Company's leadership team, led by CEO Tom Polen, embraces a management philosophy rooted in servant leadership, strategic foresight, and inclusive decision-making. Tom Polen, who joined BD in 1999, rose through the ranks with experience in marketing, operations, and M&A, reflecting the company's culture of developing talent internally. The executive leadership team includes diverse backgrounds—from engineering to finance—and a shared commitment to BD's mission. The management philosophy emphasizes 'Leading with Purpose,' which means aligning business goals with social impact. BD's leaders encourage a growth mindset, fostering experimentation and learning from failures. The company's approach to talent development includes robust succession planning, leadership development programs (e.g., BD University), and mentoring networks. Decision-making is data-driven, leveraging analytics dashboards that track performance in real-time. BD's leadership style also emphasizes employee engagement; the company conducts regular 'pulse' surveys to gather feedback and acts on it. The C-suite is accessible through town hall meetings and an open-door policy. BD's management has navigated significant challenges, such as integrating the massive Bard acquisition while maintaining operational continuity. The philosophy of 'One BD' promotes cross-functional collaboration and silo-breaking. The board of directors includes independent members with expertise in healthcare, technology, and sustainability, providing strong oversight. BD's leaders also champion diversity, equity, and inclusion (DEI) by setting measurable targets, such as increasing representation of women and people of color in senior roles. The company's supplier diversity program ensures that minority- and women-owned businesses are included in the supply chain. BD's management is known for its ethical stance; for instance, the company voluntarily discontinued sales of certain products that posed safety risks. The leadership team also emphasizes transparent communication, especially during crises like the pandemic, when supply chain disruptions required frequent updates. BD's management philosophy is validated by consistently high employee satisfaction scores on Glassdoor and recognition as a best place to work for women and veterans. By fostering a culture of empowerment and accountability, BD's leadership ensures that the organization remains agile and resilient in a rapidly changing healthcare landscape.

9. Corporate Events, Conferences, and Community Engagement

Becton, Dickinson and Company actively participates in and sponsors major industry events, conferences, and tradeshows to showcase its innovations and engage with stakeholders. Key events include the Association for the Advancement of Medical Instrumentation (AAMI) Meeting, the American Society for Microbiology (ASM) Microbe Conference, and the Radiological Society of North America (RSNA) Annual Meeting. BD also hosts its own customer events, such as the BD Innovation Summit, where thought leaders discuss the future of medication management and diagnostics. The company's community engagement is robust, centered around the BD Foundation, which funds global health initiatives, STEM education, and disaster relief. BD employees routinely volunteer through the BD Builds program, which supports community gardens, healthcare access projects, and skills-based volunteering. Notable community partnerships include collaboration with the American Red Cross for blood drives and with UNICEF for safe injection practices in developing countries. BD also engages with local communities near its manufacturing sites, such as in Canaan, Connecticut, and Tempe, Arizona, by sponsoring health fairs, scholarships, and environmental cleanup events. The company's commitment to health equity led to the HD for Health program, which provides diagnostic testing to underserved populations. BD also hosts webinars and training sessions for healthcare professionals, focusing on best practices in infection control and proper use of medical devices. The company's presence at global health conferences, like the World Health Summit, allows BD to influence global health policy. BD also holds annual employee events like the BD Day of Service, where thousands of employees worldwide participate in volunteer activities. Additionally, BD's corporate communications team regularly issues press releases and publishes thought leadership articles in trade journals, enhancing its reputation as a subject matter expert. The company's engagement extends to patient advocacy groups, such as the American Diabetes Association, where BD co-develops educational resources. BD's environmental stewardship is demonstrated through participation in the Carbon Disclosure Project (CDP) and the Ellen MacArthur Foundation's Circular Economy 100. By maintaining an active presence on the global stage and in local communities, BD strengthens its stakeholder relationships and demonstrates corporate citizenship.

10. Employees and Workplace Culture

Becton, Dickinson and Company prides itself on a workplace culture that values diversity, inclusion, and professional growth. Employees across 50+ countries collaborate in an environment that encourages innovation and respect. The company offers comprehensive benefits, including health insurance, retirement plans, tuition assistance, and wellness programs. BD's culture is reflected in its recognition as a 'Great Place to Work' in several countries. Employee resource groups (ERGs) such as Women in BD, BD BLACK+, and BD Veterans Network provide support and networking opportunities. Performance management is based on continuous feedback and alignment with company goals, using a system called 'BD Stronger.' The company invests in upskilling through the BD Learning Academy, offering online courses and certifications. Workplace flexibility is a priority, with many roles offering hybrid or remote work options. BD's commitment to psychological safety is demonstrated by anonymous reporting channels and zero tolerance for harassment. Annual employee engagement survey results are publicized, and action plans are created based on feedback. The company's inclusive hiring practices include blind resume screening and partnerships with organizations like the National Society of Black Engineers. BD also offers paid time off for volunteering, maternity/paternity leave, and caregiver support. The physical work environment in Franklin Lakes features collaboration spaces, fitness centers, and cafeterias. Many BD sites have gyms and health clinics. The culture emphasizes recognition through peer-to-peer awards and annual CEO awards for outstanding contributions. BD's internal communications use digital platforms like Workday and Microsoft Teams to keep employees informed and connected. The company also celebrates milestones like cultural heritage months and LGBTQ+ Pride. BD's low turnover rate compared to industry averages suggests high job satisfaction. Employees report feeling proud to work for a company that saves lives and makes a tangible impact. BD's commitment to workplace safety is evident in rigorous protocols, especially in manufacturing plants. Overall, the culture is professional, supportive, and mission-driven, attracting top talent from diverse backgrounds.

11. Job Details & Requirements for this Posting

Position: Senior Quality Systems Engineer

Location: Franklin Lakes, NJ (Hybrid – 3 days onsite)

Job Type: Full-time

Salary Range: $90,000 - $130,000 per year, plus bonus eligibility and benefits

About the Role: As a Senior Quality Systems Engineer at Becton, Dickinson and Company, you will be responsible for driving continuous improvement in the quality management system (QMS) for medical device manufacturing. You will work cross-functionally with R&D, manufacturing, clinical affairs, and regulatory teams to ensure compliance with FDA QSR, ISO 13485, MDR, and other global standards. This role is critical to BD's mission of delivering safe, effective products to patients worldwide.

Responsibilities:

• Lead CAPA investigations, root cause analysis, and implementation of corrective actions across product lines.
• Develop and maintain QMS documentation including SOPs, work instructions, and quality plans.
• Manage internal and external audits (FDA, Notified Body, customer audits) and coordinate audit responses.
• Perform risk management per ISO 14971 and facilitate FMEA sessions for new product introductions.
• Analyze quality metrics (e.g., nonconformities, complaint rates) to identify trends and drive preventative actions.
• Mentor junior engineers and provide training on quality principles and regulatory requirements.
• Support design control activities including design reviews, verification/validation, and design transfer.
• Collaborate with supplier quality to ensure incoming materials meet specifications.
• Drive continuous improvement initiatives using Lean, Six Sigma, or similar methodologies.
• Ensure timely reporting of adverse events per regulatory requirements.

Qualifications:

• Bachelor's degree in Mechanical Engineering, Biomedical Engineering, or related field; Master's preferred.
• 5+ years of experience in quality engineering within medical devices or other regulated industries.
• Certified Quality Engineer (CQE) or Lean Six Sigma Green/Black Belt strongly preferred.
• In-depth knowledge of ISO 13485:2016, 21 CFR Part 820, EU MDR, and ISO 14971.
• Experience with CAPA, audit management, and statistical analysis tools (e.g., Minitab).
• Strong problem-solving skills using techniques like 5 Whys, Fishbone, and FMEA.
• Excellent communication skills and ability to influence cross-functional teams without direct authority.
• Experience with SCADA, PLM, and QMS software (e.g., SAP, ETQ) preferred.
• Ability to manage multiple projects and prioritize in a fast-paced environment.
• Fluency in English; additional languages are a plus.

Why Join Becton, Dickinson and Company? BD offers an opportunity to work with cutting-edge technologies that save lives. Employees enjoy competitive compensation, advancement opportunities, and a culture that values innovation. You will be part of a global leader with a strong track record of stability and growth. BD's commitment to employee development means you can shape your career path through internal mobility. Plus, the company's focus on sustainability and social impact gives meaning to your work. By joining BD, you become part of a team that is shaping the future of healthcare.

12. Customer Reviews and Industry Reputation (1200+ words)

Glassdoor

On Glassdoor, Becton, Dickinson and Company holds an overall rating of 4.0 out of 5 stars based on over 10,000 reviews. Employees consistently praise the company's mission-driven work, global impact, and collaborative culture. Common positive themes include good work-life balance, robust benefits, and opportunities for career growth. Many reviews highlight BD's strong ethics and commitment to quality. However, some employees have expressed concerns about bureaucracy, especially in larger departments, and occasional silos between segments. The CEO approval rating is 82%, reflecting confidence in leadership. Recent reviews from the past year mention positive changes in remote work policies and increased recognition during the pandemic. Overall, Glassdoor data suggests BD is a solid employer with high employee satisfaction relative to industry peers.

Indeed

On Indeed, BD earns 4.1 out of 5 stars from over 5,000 reviews. Similar to Glassdoor, employees commend the company's focus on safety and innovation. The compensation and benefits are rated highly, particularly the 401(k) match and health insurance. Management is often described as supportive, especially in R&D and manufacturing roles. A few reviews note that promotion can be slow in some divisions, but training programs are available. Temporary and contract workers sometimes express less satisfaction with pay. Nonetheless, BD's Indeed rating remains above average for the medical device sector.

Gartner Peer Insights

BD's products, especially its diagnostic and medication management solutions, receive favorable reviews on Gartner Peer Insights. Healthcare providers appreciate the reliability and ease of use of BD systems. The BD Pyxis automated dispensing system is often highlighted for its integration with EHRs and minimizing medication errors. Ratings average 4.3 out of 5. Some feedback points to wanting more seamless software updates and improved customer support response times. Overall, BD's devices are recognized as industry standard.

Trustpilot

On Trustpilot, BD's customer-facing tools (like the BD Veritor app) have moderate ratings around 3.5 stars. Users mention user-friendly design but occasional connectivity issues. The company has responded to feedback with software patches. BD's medical devices are not typically reviewed on Trustpilot as they are sold B2B, but the overall impression is positive.

G2

BD's laboratory informatics products, such as BD Synapsys, appear on G2 with ratings near 4.0. Users value the comprehensive nature of the reporting and compliance features. Some note a steep learning curve, but training resources help mitigate that. BD's commitment to product improvement is reflected in quarterly updates.

Google Reviews

Becton, Dickinson and Company's headquarters and other facilities receive an average 4.2 stars on Google Maps. Visitors and employees alike appreciate the modern campus, cleanliness, and secure environment. Some local community members mention BD's positive economic impact in Franklin Lakes. Negative comments often relate to traffic around the campus, but overall the reputation is strong.

LinkedIn Reputation

BD commands a strong presence on LinkedIn with over 1 million followers. The company regularly posts thought leadership content, job openings, and success stories. LinkedIn ratings from people who have worked at BD show a 4.0 out of 5 rating. The company is frequently listed as a top employer in healthcare and manufacturing categories. BD's engagement with followers is high, with quick responses to inquiries and active participation in industry discussions. The company's LinkedIn page also highlights its corporate social responsibility initiatives, enhancing its brand image.

Industry awards further solidify BD's reputation. BD has been named to the Dow Jones Sustainability World Index, recognized by Forbes as one of America's Best Employers for Diversity, and received FDA recognition for innovative products. The company's strong patent portfolio and R&D investment show its leadership. Customer testimonials from major hospital systems like the Mayo Clinic and Cleveland Clinic speak to BD's reliability. Even in crises like the pandemic, BD's rapid scaling of production garnered praise from health officials. However, like any large corporation, BD faces occasional product recalls and lawsuits—but its transparent handling of such issues maintains trust. Ultimately, BD's reputation is that of a responsible, innovative, and essential healthcare partner.

13. Why Organizations Choose Becton, Dickinson and Company

Healthcare organizations choose BD for its proven reliability, comprehensive product portfolio, and commitment to improving patient outcomes. BD’s products are backed by extensive clinical evidence, reducing adoption risk. The company’s global supply chain ensures product availability even during disruptions. BD offers integrated solutions that combine hardware, software, and services, streamlining procurement and reducing vendor complexity. For example, a hospital that uses BD blood collection tubes, BD infusion pumps, and BD pharmacy automation can link data through BD HealthSuite for total visibility. BD’s customer support includes 24/7 technical assistance, training, and predictive maintenance. The company also provides value analysis support to help organizations assess the total cost of ownership. Additionally, BD’s focus on infection prevention and medication safety aligns with hospital quality improvement goals. Many organizations appreciate BD’s co-development capabilities, where BD works with clinicians to develop custom solutions. BD’s ethical sourcing and sustainability initiatives also resonate with environmentally conscious buyers. Lastly, BD’s strong financial health and reputation as a stable partner give procurement departments confidence. For these reasons, BD is a preferred supplier for many of the world’s top healthcare institutions.

14. Official Contact Information

For inquiries and assistance, please reach out to Becton, Dickinson and Company using the following contact details:

Address: 1 Becton Drive, Franklin Lakes, NJ 07417, USA
Contact Number: +1 (201) 847-6800
Support Number: +1 (800) 866-2337
Helpdesk Number: +1 (800) 426-2266
Website: www.bd.com

15. Official Social Media Presence

Stay connected with Becton, Dickinson and Company through its official social media channels for the latest news, product updates, and career opportunities:

• LinkedIn: linkedin.com/company/bd/
• Twitter: @BDandCo
• Facebook: facebook.com/BDandCo/
• YouTube: youtube.com/user/BDandCompany
• Instagram: @bdandco

16. SEO FAQ Section

1. What does Becton, Dickinson and Company do?

Becton, Dickinson and Company is a global medical technology company that develops, manufactures, and sells medical devices, diagnostic systems, and bioscience products for healthcare institutions, life sciences researchers, and pharmaceutical companies.

Becton, Dickinson and Company is headquartered in Franklin Lakes, New Jersey, USA.

Becton, Dickinson and Company was founded in 1897 by Maxwell W. Becton and Fairleigh S. Dickinson.

The CEO of Becton, Dickinson and Company is Tom Polen, who has served since 2019.

Becton, Dickinson and Company operates through three segments: BD Medical (medication delivery and management), BD Life Sciences (diagnostics and biosciences), and BD Interventional (peripheral intervention and urology).

Yes, Becton, Dickinson and Company has a history of paying quarterly dividends and has increased its dividend for over 50 consecutive years.

Becton, Dickinson and Company reported approximately $19.3 billion in revenue for fiscal year 2023.

Becton, Dickinson and Company employs approximately 70,000 people globally.

Yes, Becton, Dickinson and Company is consistently listed on the Fortune 500, ranking #231 in 2023.

Becton, Dickinson and Company trades on the New York Stock Exchange under the ticker symbol BDX.

Becton, Dickinson and Company has acquired C. R. Bard (2017), CareFusion (2015), and KCI Medical (2021), among others.

Yes, Becton, Dickinson and Company has set goals to achieve carbon neutrality by 2040 and zero waste to landfill by 2030.

BD HealthSuite is a cloud-based digital platform from Becton, Dickinson and Company that integrates data from connected medical devices for analytics and workflow improvements.

Becton, Dickinson and Company fosters a diverse workforce through employee resource groups, inclusive hiring practices, and supplier diversity programs.

Yes, Becton, Dickinson and Company provides extensive training through BD Learning Academy, leadership programs, and technical certifications.

The mission of Becton, Dickinson and Company is 'Helping all people live healthy lives.'

Yes, Becton, Dickinson and Company regularly hires for roles in engineering, sales, R&D, manufacturing, and corporate functions globally.

Yes, Becton, Dickinson and Company adheres to a strict Code of Conduct that emphasizes integrity, compliance, and ethical behavior.

The core values are Integrity, Customer Focus, Innovation, Collaboration, and Accountability.

Through the BD Foundation, employee volunteerism, and partnerships, Becton, Dickinson and Company supports health equity, disaster relief, STEM education, and safe injection practices worldwide.

For professionals seeking comprehensive market research and industry insights, exploring resources like Guest Post Backlinks can complement understanding of the healthcare sector. Becton, Dickinson and Company (BD) continues to lead through innovation and reliability, and staying informed via authoritative platforms is essential for industry stakeholders. Becton, Dickinson and Company's official website offers detailed product information, career opportunities, and investor materials, while external publications provide additional perspectives on medical technology trends and corporate strategies.